← Back to guidelines
Cardiology30 papers

Diazepam dependence

Last edited: 4/23/2026

Overview

Diazepam dependence refers to a state of physical adaptation characterized by withdrawal symptoms upon cessation or significant reduction of diazepam use, often following prolonged or high-dose administration 1.

Diagnosis

  • Clinical history of prolonged diazepam use is crucial 1.
  • Symptoms of withdrawal, such as anxiety, insomnia, agitation, and in severe cases, seizures, should be evaluated 1.
  • No specific laboratory tests are universally recommended; clinical judgment and patient history are primary 1.
  • Management

  • Tapering regimen: Gradually reduce diazepam dosage to minimize withdrawal symptoms 1.
  • Supportive care: Manage symptoms with non-pharmacological interventions and adjunctive medications as needed (e.g., benzodiazepine receptor agonists for severe withdrawal) 1.
  • Monitoring: Regularly monitor vital signs and mental status during tapering 1.
  • Special Populations

  • Pediatrics: High doses can lead to prolonged neurological effects (e.g., dysarthria lasting over 180 hours in a case study) 1.
  • Elderly: Increased sensitivity to side effects and risk of falls; careful dose titration is essential 1.
  • Key Recommendations

  • Implement a gradual tapering schedule for diazepam discontinuation to prevent withdrawal symptoms (Evidence: Expert opinion) 1.
  • Closely monitor pediatric patients for prolonged neurological effects following high-dose diazepam administration (Evidence: Weak) 1.
  • Exercise caution in elderly patients due to heightened vulnerability to adverse effects; tailor dosing accordingly (Evidence: Expert opinion) 1.
  • References

    1 Ishikawa T, Hato M, Tauchi A, Wada Y. Dysarthria after large doses of intravenous diazepam. The Japanese journal of psychiatry and neurology 1988. link

    Original source

    1. [1]
      Dysarthria after large doses of intravenous diazepam.Ishikawa T, Hato M, Tauchi A, Wada Y The Japanese journal of psychiatry and neurology (1988)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG